Not Medicare Enrolled

Dr. John Naus, MD

Psychiatry · Colleyville, TX
Speaking/Promotional
5017 HERITAGE AVE, Colleyville, TX 76034
8175459100
In practice since 2007 (18 years)
NPI: 1932328291 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Naus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naus? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Naus

Dr. John Naus is a psychiatry in Colleyville, TX, with 18 years in practice.

Between the years covered by Open Payments, Dr. Naus received a total of $187,565 from 42 pharmaceutical and/or device companies across 913 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Naus is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice$ $187,565 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$187,565
Total received (2018-2024)
Avg $26,795/year across 7 years
Top 2% in TX for psychiatry
42
Companies
913
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$177,857 (94.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,708 (5.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$23,149
2023
$28,402
2022
$19,599
2021
$20,964
2020
$2,756
2019
$28,185
2018
$64,511

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$56,713
Sunovion Pharmaceuticals Inc.
$42,361
Supernus Pharmaceuticals, Inc.
$29,883
Teva Pharmaceuticals USA, Inc.
$24,025
Takeda Pharmaceuticals U.S.A., Inc.
$11,719
Neos Therapeutics, LP
$9,869
Allergan Inc.
$3,100
E.R. Squibb & Sons, L.L.C.
$2,386
ITI, Inc.
$1,542
Validus Pharmaceuticals LLC
$749
Neurocrine Biosciences, Inc.
$691
Lundbeck LLC
$602
Axsome Therapeutics, Inc.
$448
Corium, LLC
$441
Otsuka Pharmaceutical Development & Commercialization, Inc.
$389
Vanda Pharmaceuticals Inc.
$382
Janssen Pharmaceuticals, Inc
$229
Alkermes, Inc.
$222
Shire North American Group Inc
$221
Tris Pharma Inc
$162
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$145
ABBVIE INC.
$132
JAZZ PHARMACEUTICALS INC.
$130
ARBOR PHARMACEUTICALS, INC.
$127
Ironshore Pharmaceuticals Inc.
$123
Avanir Pharmaceuticals, Inc.
$119
Vertical Pharmaceuticals, LLC
$92
Noven Therapeutics, LLC
$83
Jazz Pharmaceuticals Inc.
$83
Allergan, Inc.
$68
IDORSIA PHARMACEUTICALS US INC
$59
Bausch Health US, LLC
$39
Masimo Corporation
$36
Avadel CNS Pharmaceuticals, LLC
$32
Merck Sharp & Dohme LLC
$31
Almatica Pharma LLC
$29
Adlon Therapeutics L.P.
$28
Harmony Biosciences LLC
$18
IRONSHORE PHARMACEUTICALS INC.
$17
AbbVie Inc.
$17
EISAI INC.
$12
OWP Pharmaceuticals, Inc.
$11
Top 3 companies account for 68.8% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · DIVIGEL · Dayvigo · Dyanavel XR · Equetro · Evekeo · Fanapt · HETLIOZ · Hetlioz · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LUMRYZ · LYBALVI · Lamotrigine Starter Kit · METHYLPHENIDATE 72 · MYDAYIS · NUEDEXTA · QELBREE · QUVIVIQ · Qelbree · RELEXXII · REXULTI · SECUADO · SERTRALINE HCL · SPRAVATO · SUNOSI · Sunosi · TRINTELLIX · Trintellix · UZEDY · VIIBRYD · VRAYLAR · VYVANSE · Wakix · XIIDRA · XYREM · XYWAV · Xelstrym · Xyrem
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for psychiatry in TX.

Looking for a psychiatry in Colleyville?
Compare psychiatrys in the Colleyville area by procedure volume, costs, and industry payment transparency.
Browse psychiatrys nearby

Geographic Context

Psychiatrys within 10 mi
608
Per 100K population
28.5
County median income
$81,905
Nearest hospital
SAINT CAMILLUS MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Naus is a psychiatry, and high industry engagement (speaking/promotional, top 2%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Naus receive payments from pharmaceutical companies?
Yes. Dr. Naus received a total of $187,565 from 42 companies across 913 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Naus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →